| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
3,758 |
2,930 |
$204K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,197 |
1,400 |
$114K |
| 92134 |
|
5,458 |
4,339 |
$105K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
926 |
789 |
$64K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
584 |
487 |
$60K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,051 |
921 |
$50K |
| 92235 |
|
286 |
255 |
$23K |
| 92250 |
|
574 |
489 |
$16K |
| J3590 |
Unclassified biologics |
969 |
667 |
$9K |
| J0178 |
Injection, aflibercept, 1 mg |
16 |
13 |
$6K |
| 4040F |
|
75 |
64 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
12 |
12 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
97 |
89 |
$0.00 |